Question 1

How big is the preimplantation genetic testing market?

Accepted Answer

The global preimplantation genetic testing industry was valued at USD 780.8 million in 2023 and is estimated to grow at a 9.4% CAGR from 2024 to 2032, driven by the increasing prevalence of genetic disorders in newborns and rising awareness of reproductive health.

Question 2

Why is the product segment dominant in the preimplantation genetic testing industry?

Accepted Answer

The product segment dominated the market and is anticipated to grow at a 9.3% CAGR over the forecast period, as it includes essential reagents, sequencing kits, and testing consumables required for accurate embryo testing in IVF procedures.

Question 3

How much is the U.S. preimplantation genetic testing market worth?

Accepted Answer

U.S. accounted for USD 312.2 million in the North American preimplantation genetic testing industry in 2023 and is expected to maintain its dominance throughout the forecast period, attributed to the widespread adoption of advanced reproductive technologies and growing awareness of genetic screening.

Question 4

Who are some of the prominent players in the preimplantation genetic testing industry?

Accepted Answer

Key players in the industry include Agilent Technologies, Fulgent Genetics, Genea BIOMEDX, Illumina, Medicover Genetics, Natera, and Revvity.

Preimplantation Genetic Testing Market Share

Preimplantation Genetic Testing Market Share

Preimplantation Genetic Testing Market Companies

Premium Report Details

Industries

Information

Link

Global Headquarters